Genetics of both virus and patient work together to influence the course of HIV infection

February 9, 2017
HIV, the AIDS virus (yellow), are infecting a human cell. Credit: ZEISS Microscopy / Flickr

Viral and human genetics together account for about one third of the differences in disease progression rates seen among people infected with the human immunodeficiency virus (HIV), according to new research published in PLOS Computational Biology. The findings suggest that patient genetics influences disease progression by triggering mutations in the HIV viral genome.

People with HIV experience different rates of . HIV progresses faster in people with a higher —the amount of genetic material from the HIV virus found in an infected person's blood.

Previous research has shown that an infected person's genetics and the genetics of their particular HIV strain both influence viral load. István Bartha of École Polytechnique Fédérale de Lausanne, Switzerland, and colleagues are now the first scientists to investigate the relative impacts of human and viral genetics on viral load within the same group of patients.

The researchers collected patient and viral genetic data from 541 people with HIV. They used a computational modeling method known as linear mixed modeling to determine how human and viral genetics might explain differences in viral load between the patients.

They found that genetic differences between HIV strains explain 29 percent of differences in viral load between patients, while human genetic variation explains 8.4 percent. Together, they explain just 30 percent of viral load variation, indicating that patient genetics exert most of its influence by inducing genetic mutations in the HIV virus as it multiplies inside the patient.

"Our paper demonstrates that the genetic make-up of both the patient and the infecting virus contribute to the clinical course of HIV infection," says study director Jacques Fellay.

Further research with a larger group of patients is needed to confirm and refine the findings. Nonetheless, "combining host and pathogen data gave us new insight into the genetic determinants of HIV control," Fellay says. "A similar strategy could be used to better understand other chronic infectious diseases."

Explore further: New antiretroviral drugs decrease chances of HIV sexual transmission

More information: Bartha I, McLaren PJ, Brumme C, Harrigan R, Telenti A, Fellay J (2017) Estimating the Respective Contributions of Human and Viral Genetic Variation to HIV Control. PLoS Comput Biol 13(2): e1005339. DOI: 10.1371/journal.pcbi.1005339

Related Stories

New antiretroviral drugs decrease chances of HIV sexual transmission

November 22, 2016
More than 2 million people were infected by human immunodeficiency virus (HIV) in 2015 via sexual transmission. Researchers from the Bellvitge Biomedical Research Institute (IDIBELL), led by Dr. Daniel Podzamczer, have evaluated ...

Potential evidence of lung-specific Ebola infection found in recovering patient

January 5, 2017
Scientists have found potential evidence of Ebola virus replication in the lungs of a person recovering from infection, according to new research published in PLOS Pathogens. The findings could aid research into new treatment ...

Research effort reveals gene variants that play a role in HIV viral load in patients

November 10, 2015
(Medical Xpress)—A large international team of researchers has conducted a study that has shed some light on the role genetic variation plays on HIV viral load levels in patients infected with the virus. In their paper ...

High viral load in HIV-infected individuals underlies innate immune cell dysfunction

March 17, 2016
Individuals infected with HIV exhibit both severe immune deficiency and aberrant inflammation, resulting in susceptibility to secondary infection as the disease progresses. HIV-associated deficiencies in adaptive immune responses ...

Blood test can predict life or death outcome for patients with Ebola virus disease

January 19, 2017
Scientists have identified a 'molecular barcode' in the blood of patients with Ebola virus disease that can predict whether they are likely to survive or die from the viral infection.

Better long-term outcomes with low hep C viral load

March 25, 2013
(HealthDay)—In patients with hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC), low HCV viral load predicts better long-term surgical outcomes, regardless of the serologic eradication of HCV, according to research ...

Recommended for you

New injectable antiretroviral treatment proved to be as effective as standard oral therapy

August 3, 2017
Intramuscularly administered antiretroviral therapy (ART) may be as effective for HIV treatment as current oral therapies. This is the main conclusion of a Phase II clinical trial carried out by 50 research centers around ...

Research finds home-based kit would increase HIV testing

July 31, 2017
Research led by William Robinson, PhD, Associate Research Professor of Behavioral & Community Health Sciences at LSU Health New Orleans School of Public Health, has found that 86% of heterosexuals who are at high risk for ...

Scientists divulge latest in HIV prevention

July 25, 2017
A far cry from the 1990s "ABC" campaign promoting abstinence and monogamy as HIV protection, scientists reported on new approaches Tuesday allowing people to have all the safe sex they want.

Girl's HIV infection seems under control without AIDS drugs

July 24, 2017
A South African girl born with the AIDS virus has kept her infection suppressed for more than eight years after stopping anti-HIV medicines—more evidence that early treatment can occasionally cause a long remission that, ...

Meds by monthly injection might revolutionize HIV care (Update)

July 24, 2017
Getting a shot of medication to control HIV every month or two instead of having to take pills every day could transform the way the virus is kept at bay.

Candidate AIDS vaccine passes early test

July 24, 2017
The three-decade-old quest for an AIDS vaccine received a shot of hope Monday when developers announced that a prototype triggered the immune system in an early phase of human trials.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

lisamcclean360
not rated yet Feb 09, 2017
I never taught Dr ILLUOBE who could ever get my HIV-AIDS cured with his herbal product.despite all these happening to me.I always spend a lot to buy a HIV drugs from hospital and taking some several medications but no relieve until one day i was just browsing on the internet when i came across a great post of ! Williams Fran-ca who truly said that she was been diagnose with HIV and was healed that very week through the help of these great powerful healing spell doctor. sometime i really wonder why people called him Dr ILLUOBE,i never knew it was all because of the great and perfect work that he has been doing that is causing all this. so i quickly contacted him and he ask me some few questions and he said a thing i will never forget that anyone who contacted him is always getting his or her healing in just 6 hours after doing all he ask you so i was amazed all the time i heard that from him ,so i did all things only to see that at the very day which he said i will be healed all the st

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.